https://www.cnn.com/2022/11/01/health/rsv-vaccine-pfizer-fda/index.html#amp_tf=From%20%251%24s&aoh=16673922883743&referrer=https%3A%2F%2Fwww.google.com&ampshare=https%3A%2F%2Fwww.cnn.com%2F2022%2F11%2F01%2Fhealth%2Frsv-vaccine-pfizer-fda%2Findex.html https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8078688/ (CNN) Pfizer says it has enough promising data on its respiratory syncytial virus, or RSV, vaccine designed to protect newborns that it will end enrollment in the study and submit for US Food and Drug Administration approval by the end of the year. RSV is a common respiratory virus that typically causes mild, … Continue reading RSV vaccine trial shows promising results, Pfizer says; company will seek FDA approval this year – CNN..